Illumina, Pacific Biosciences enter FTC timing agreement not to close deal until midyear
MLex Summary: Illumina and Pacific Biosciences have entered a timing agreement with the US Federal Trade Commission in its review of their merger that extends the waiting period to mid 2019,...To view the full article, register now.
Already a subscriber? Click here to view full article